January 18-22, 2016 | Town and Country Resort Hotel | SAN DIEGO, CA 
January 18-22, 2016 | Town and Country Resort Hotel | SAN DIEGO, CA 

Pipeline Two Icon Pipeline Two Header 

Cambridge Healthtech Institute’s 5th Annual
Bispecific Antibody Therapeutics
Engineering Multispecificity
January 21-22, 2016

Creating bioactive molecules that are multivalent and multifunctional offers the promise of more effective therapies. Empowered antibodies bind to at least two molecular targets simultaneously, thereby delivering a highly potent therapeutic, particularly for cancer. The Bispecific Antibody Therapeutics meeting explores the challenges of engineering multispecificity to ensure stability and efficacy, and reviews the numerous forms of multispecific antibodies in development, including next-generation antibody formats. Case studies highlight safety issues, along with preclinical and clinical data. Join colleagues from around the world in this discussion of the exciting breakthroughs in engineering antibodies, and see how cancer and other applications are advancing into a true therapeutic revolution.

We invite presentation proposals on the following preliminary topics: 

  • Case studies
  • Preclinical and clinical data
  • Cancer
  • Antitumor activity
  • Tumor specific antigens (TSAs)
  • Stability
  • Crossing the blood-brain barrier (BBB)
  • Bi- and trispecific antibodies
  • Engineering multivalency
  • Variable domains
  • Binding specificities
  • Bispecific T-cell engagers (BiTEs)
  • Antibody mimetics
  • Antibody-antigen binding kinetics
  • Immunogenicity
  • Effector functions

Please click here to submit a speaking proposal for review.

Deadline for submission: June 17, 2015 

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For questions about the meeting, please contact: 

For partnering & sponsorship information, please contact: 

Mary Ruberry
Senior Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5421
Email: mruberry@healthtech.com 

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com 

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com